selenomethionine has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kozak, YS; Lehka, LV; Moiseenok, AG; Panchuk, RR; Skorokhyd, NR; Stoika, RS | 1 |
| Chung, AS; Kim, A; Oh, JH; Park, JM | 1 |
2 other study(ies) available for selenomethionine and B16 Melanoma
| Article | Year |
|---|---|
Tissue-protective activity of selenomethionine and D-panthetine in B16 melanoma-bearing mice under doxorubicin treatment is not connected with their ROS scavenging potential.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Dose-Response Relationship, Drug; Doxorubicin; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Pantetheine; Reactive Oxygen Species; Selenomethionine | 2017 |
Methylselenol generated from selenomethionine by methioninase downregulates integrin expression and induces caspase-mediated apoptosis of B16F10 melanoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carbon-Sulfur Lyases; Caspase Inhibitors; Caspases; Cell Adhesion; Cell Cycle; Cell Proliferation; Cell Shape; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Extracellular Matrix; Focal Adhesion Kinase 1; I-kappa B Proteins; Integrins; Melanoma, Experimental; Methanol; Mice; Organometallic Compounds; Organoselenium Compounds; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C-delta; Proto-Oncogene Proteins c-akt; Selenomethionine; Signal Transduction; Skin Neoplasms; Sodium Selenite | 2007 |